¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"nitroblue tetrazolium reduction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nitroblue tetrazolium test
    ´ÏÆ®·Îºí·çÅׯ®¶óÁ¹·ý°Ë»ç
  • barium reduction
    ¹Ù·ýÁ¤º¹(¼ú)
  • breast reduction
    À¯¹æÁÙÀÓ(¼ú), À¯¹æÃà¼Ò(¼ú)
  • closed reduction
    ºñ°³¹æÁ¤º¹(¼ú), Æó¼âÁ¤º¹(¼ú)
  • forehead reduction
    À̸¶Ãà¼Ò(¼ú), À̸¶¼ºÇü(¼ú)
  • false reduction
    °¡Á¤º¹, °¡È¯³³, °ÅÁþ¸ÂÃã
  • mandibular angle reduction
    ÅλÀ°¢Ãà¼Ò(¼ú), ÇϾǰ¢Ãà¼Ò(¼ú)
  • nitrate reduction
    Áú»ê¿°È¯¿ø
  • open reduction
    °³¹æÁ¤º¹(¼ú)
  • oxidation-reduction
    »êȭȯ¿ø
  • oxidation-reduction potential
    »êȭȯ¿øÀüÀ§
  • oxidation-reduction system
    »êȭȯ¿ø°è
  • proportional reduction
    ºñ·Ê°¨¼Ò
  • reduction
    1. ¸ÂÃã, ±³Á¤, Á¤º¹(¼ú) 2. ȯ¿ø 3. Ãà¼Ò(¼ú) 4. ¾àºÐ
  • reduction division
    °¨¼öºÐ¿­
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nitroblue tetrazolium test
    ´ÏÆ®·Îºí·çÅׯ®¶óÁ¹·ý°Ë»ç
  • oxidation-reduction
    »êȭȯ¿ø
  • reduction
    1.¸ÂÃã, ±³Á¤, Á¤º¹, 2.ȯ¿ø, Ãà¼Ò
  • barium reduction
    ¹Ù·ý±³Á¤¼ú
  • breast reduction
    À¯¹æÁÙÀÓ¼ú, À¯¹æÃà¼Ò¼ú
  • closed reduction
    ºñ°³¹æ±³Á¤(¼ú)
  • mandibular angle reduction
    ÅλÀ°¢Ãà¼Ò¼ú, ÇϾǰ¢Ãà¼Ò¼ú
  • open reduction
    °³¹æ±³Á¤(¼ú)
  • reduction rhinoplasty
    ÄÚÃà¼Ò¼ú, Ãà¼ÒÄÚ¼ºÇü¼ú
  • reduction test
    ȯ¿ø½ÃÇè
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • breast reduction
    À¯¹æÁÙÀÓ¼ú, À¯¹æÃà¼Ò¼ú
  • closed reduction
    Æó¼â°ñÀý±³Á¤, Æó¼âµÇ¸ÂÃã¼ú
  • egg reduction rate
    Ãæ¶õ°¨¼ÒÀ²
  • false reduction
    °¡Á¤º¹, °¡È¯³³, °ÅÁþ¸ÂÃã
  • forehead reduction
    À̸¶»è°¨¼ú, À̸¶¼ºÇü¼ú
  • mandibular angle reduction
    ÅλÀ°¢Ãà¼Ò¼ú, ÇϾǰ¢Ãà¼Ò¼ú
  • silver reduction method
    ÀºÈ¯¿ø¹ý
  • nitrate reduction
    Áú»ê¿°È¯¿ø
  • oxidation-reduction
    »êȭȯ¿ø
  • open reduction
    °³¹æ°ñÀý±³Á¤, ¿­¸²µÇ¸ÂÃã¼ú
  • oxidation-reduction potential
    »êȭȯ¿øÀüÀ§
  • oxidation-reduction system
    »êȭȯ¿ø°è
  • oxidation-reduction titration
    »êȭȯ¿øÀûÁ¤
  • proportional reduction
    ºñ·Ê°¨·Â
  • reduction potential
    ȯ¿øÀüÀ§
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • plaque reduction neutralization test
    ÇöóÅ© °¨¼ÒÁßÈ­½ÃÇè
  • plaque reduction test
    ÇöóÅ© °¨¼Ò½ÃÇè
  • pock reduction test
    Æø °¨¼ÒÁßÈ­½ÃÇè
  • reduction
    Á¤º¹¼ú, °¨¼Ò, Ãà¼Ò
  • reduction
    ȯ¿ø(ü½êª), °¨¼Ò.
  • reduction
    Á¤º¹, °¨¼Ò
  • reduction discharge
    ȯ¿ø¼º¹æ.
  • reduction division
    °¨¼öºÐ¿­(Êõâ¦ÝÂæñ).
  • reduction division
    °¨¼öºÐ¿­
  • reduction division
    °¨¼öºÐ¿­
  • reduction in area
    ´Ü¸é¼öÃà·ü(Ó¨Øüâ¥õêëÒ).
  • reduction of cardiac work load
    ½ÉÀÛ¾÷·®ÀÇ °æ°¨(ãýíÂåöåÖ¡­ÌîÊõ).
  • reduction of chromosome
    ¿°»öü°¨¼ö(æøßäô÷Êõâ¦).
  • reduction of fraction
    ¾àºÐ(å³ÝÂ).
  • reduction of fracture
    °ñÀý Á¤º¹(Íéï¹ïÚÜÖ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nitroblue tetrazolium dye test
  • nitroblue tetrazolium test
    ´ÏÆ®·Îºí·çÅׯ®¶óÁ¹¸®¿ò½ÃÇè
  • closed reduction
    µµ¼öÁ¤º¹(Óùâ¢ïÚÜÙ), ºñ°üÇ÷Àû(°ñ)Á¤º¹¼ú(ުκúìîÜÍéïÚÜÖâú).
  • copper reduction test
    ±¸¸®È¯¿ø½ÃÇè
  • dose-reduction factor
    ¼±·®°¨¼Ò°è¼ö
  • false reduction
    °¡ ȯ³³(Ê£ü½Ò¡), °¡ Á¤º¹.
  • methylene blue reduction test
    ¸ÞÆ¿·»ºí·ç ¿ìȯ¿ø½ÃÇè(¡­ü»êªãËúÐ).
  • nitrate reduction
    Áú»ê¿°È¯¿ø(òòß«ç¤ü½êª).
  • nitrate reduction test
    Áú»ê¿°È¯¿ø½ÃÇè(~ãËúÐ).
  • open reduction
    °³¹æ¼º Á¤º¹(ËÒÛ¯àõïÚÜÖ), °üÇ÷Àû Á¤º¹ °ñÀý(κúìîÜïÚÜÖÍéï¹), ~ÀÇ .
  • oxidation reduction potential
    »êÈ­-ȯ¿øÀüÀ§
  • oxidation reduction potential =redox p.
    »êȭȯ¿øÀüÀ§.
  • oxidation reduction system =redox s.
    »ê ȭȯ¿ø°è.
  • oxidation reduction titration =redox t.
    »ê ȭȯ¿øÀûÁ¤(¡­îÙïÒ).
  • plaque reduction neutralization test
    ÇöóÅ© °¨¼ÒÁßÈ­½ÃÇè
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Reduction division
    °¨¼öºÐ¿­
    [¿¾ ¿ë¾î] °¨¼öºÐ¿­
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • egg reduction rate
    Ãæ¶õ°¨¼ÒÀ²
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • assimilatory reduction
    µ¿È­Àûȯ¿ø (ÔÒûùîÜü½êª)
  • biological oxidation-reduction
    »ýü »êȭȯ¿ø(ßæô÷ß«ûùü½êª)
  • carbon reduction cycle
    ź¼Ò ȯ¿ø ȸ·Î(÷©áÈü½êªüÞÖØ)
  • catalytic reduction method
    Ã˸Åȯ¿ø¹ý(õºØÚü½êªÛö)
  • dissimilatory reduction
    ÀÌÈ­ ȯ¿ø(ì¶ûùü½êª)
  • nitrate reduction
    Áú»êȯ¿ø(òòß«ü½êª)
  • oxidation-reduction enzyme
    »êȭȯ¿ø È¿¼Ò(ß«ûùü½êªý£áÈ)
  • oxidation-reduction potential
    »êȭȯ¿ø ÀüÀ§(ß«ûùü½êªï³êÈ)
  • oxidation-reduction reaction
    »êȭȯ¿ø ¹ÝÀÀ(ß«ûùü½êªÚãëë)
  • plaque reduction method
    ÇöóÅ© °¨¼Ò¹ý(Êõá´Ûö)
  • reduction
    "ȯ¿ø(ü½êª), °¨¼Ò(Êõá´)"
  • reduction division
    °¨¼öºÐ¿­(Êõâ¦ÝÂæñ)
  • reduction phase
    ȯ¿ø±â(ü½êªÑ¢)
  • reduction potential
    ȯ¿ø ÀüÀ§(ü½êªï³êÈ)
  • respiratory reduction
    È£Èí¼º ȯ¿ø(û¼ýåàõü½êª)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • open reduction
    °üÇ÷ÀûÁ¤º¹
  • reduction
    Á¤º¹, °¨¼Ò, ȯ¿ø
  • reduction of fracture
    °ñÀýÁ¤º¹
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NBT nitroblue tetrazolium; non-tumor-bearing; normal breast tissue
NTD neural tube defect; nitroblue tetrazolium dye; noise tone difference; 5'-nucleotidase
PNBT p-nitroblue tetrazolium
NBT test Nitro-Blue Tetrazolium (dye reduction) test
  ; Chronic Granulomatous DiseaseÁø´Ü¿¡ »ç¿ë...
TR recovery time; rectal temperature; repetition time; residual tuberculin; terminal repeat; tetrazoliu...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NBT Nitroblue tetrazolium dye
NBT Nitroblue tetrazolium test
TTC 2'3'5-triphenyl tetrazolium chloride
TTC 5-triphenyl tetrazolium chloride
MTT Methyl thiazol tetrazolium
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • nitroblue tetrazolium test
    ´ÏÆ®·Î ºí·ç Åׯ®¶ó Á¹¸®¿ò ½ÃÇè
  • bone reduction procedure
    °ñ Á¦°Å¼ú
  • closed reduction
    ºñ°üÇ÷Àû °ñ Á¤º¹¼ú
  • disc dislocation with reduction
    Á¤º¹¼º °üÀý¿øÆÇ ÀüÀ§
  • disc displacement with reduction
    Á¤º¹¼º °üÀý¿øÆÇ º¯À§
    µ¿ÀǾî=reducing disc. ±³µÎ°£À§¿¡¼­ ÃøµÎÇϾǰüÀýÀÇ °üÀý¿øÆÇÀÌ º¯À§µÈ °ÍÀ¸·Î¼­ ÇÏ¾Ç °úµÎÀÇ È°Áֿ°ú ȸÀü¿îµ¿ µ¿¾È ÇÏ¾Ç °úµÎ°¡ °üÀý ¿øÆÇ°ú Á¤»óÀûÀÎ ÇØºÎÇÐÀû °ü°è¸¦ ÀçÈ®¸³ÇÑ´Ù.
  • disk displacement without reduction
    ºñÁ¤º¹¼º °üÀý¿øÆÇ º¯À§
  • distal wedge reduction
    ¿ø½É ½û±âÇü ÀýÁ¦
  • functional dislocation with reduction
    Á¤º¹¼º ±â´ÉÀû ÀüÀ§
  • interproximal reduction
    Ä¡°£ »èÁ¦
  • nitrate reduction test
    Áú»ê¿° ȯ¿ø ½ÃÇè
  • oxidation reduction system
    »êÈ­ ȯ¿ø°è
  • reduction of fracture
    °ñÀý Á¤º¹
  • silver reduction method
    Àº ȯ¿ø¹ý
  • TMJ-ID with reduction
    Á¤º¹¼º ¾Ç°üÀý ³»Àå
    ¾Ç°üÀý ³»ÀåÀÇ Ãʱ⠴ܰè·Î ¿Õº¹¼º °üÀýÀ½ÀÌ Æ¯Â¡À¸·Î ³ªÅ¸³­´Ù. ÇÏ¾Ç ¿îµ¿ ¹üÀ§´Â ´ë°³ Á¤»óÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
nitroblue tetrazolium reduction <chemical> Nitroblue tetrazolium, a yellow dye, is taken up by phagocytosing neutrophils and reduced to insoluble formazan, which is deep blue, if the metabolic burst is normal. Reduction does not take place in chronic granulomatous disease.
(18 Nov 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
nitroblue tetrazolium <chemical> 3,3'-(3,3'-dimethoxy-4,4'-biphenylene)bis (2-(p-nitrophenyl)-5-phenyl-2h-tetrazolium. Colourless to yellow dye that is reducible to blue or black formazan crystals by certain cells; formerly used to distinguish between nonbacterial and bacterial diseases, the latter causing neutrophils to reduce the dye; used to confirm diagnosis of chronic granulomatous disease.
Pharmacological action: indicators and reagents.
Chemical name: 2H-Tetrazolium, 3,3'-(3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)bis(2-(4-nitrophenyl)-5-phenyl-, dichloride
(12 Dec 1998)
nitroblue tetrazolium test A test to detect the phagocytic ability of polymorphonuclear leukocytes by measuring the capacity of the oxygen-dependent leukocytic bactericidal system.
(05 Mar 2000)
amine tetrazolium reductase <enzyme> Tetrazolium salts as hydrogen acceptors
Registry number: EC 1.4.-
Synonym: tryptamine dehydrogenase, monoamine tetrazolium reductase, monoamine dehydrogenase
(26 Jun 1999)
NADH tetrazolium reductase <enzyme> Catalyses the reduction of tetrazolium compounds in the presence of NADH.
Registry number: EC 1.6.-
(12 Dec 1998)
NADPH-tetrazolium reductase <enzyme> Reported to possess activity identical with NADPH cytochrome c reductase EC 1.6.2.4
Registry number: EC 1.6.2.-
Synonym: NADPH-neotetrazolium reductase, NADPH-nbt reductase
(26 Jun 1999)
tetrazolium Any of a group of organic salts having the general structure which on reduction (cleaving the 2,3 bond) yields a coloured insoluble formazan; used as a reagent in oxidative enzyme histochemistry.
Nitroblue tetrazolium (NBT), a pale yellow dye that is converted on reduction to coloured formazans in the histochemical demonstration of dehydrogenases; used in haematology for staining of neutrophils to help indicate the presence of bacterial infections.
(05 Mar 2000)
tetrazolium salts <chemical> Quaternary salts derived from tetrazoles. They are used in tests to distinguish between reducing sugars and simple aldehydes, for detection of dehydrogenase in tissues, cells, and bacteria, for determination of corticosteroids, and in colour photography.
Pharmacological action: indicators and reagents.
(12 Dec 1998)
acetyl reduction assay <investigation> A technique for measuring the nitrogen fixation activity in photosynthetic organisms. It uses a flame ionisation detector and a gas chromatography apparatus to determine the reduction of acetylene to ethylene by the enzyme nitrogenase.
(06 May 1997)
reduction <orthopaedics, surgery> The correction of a fracture, dislocation or hernia.
(18 Nov 1997)
reduction deformity Congenital absence or attenuation of one or more body parts; usually of the limbs or limb components.
(05 Mar 2000)
reduction division The first cell division in meiosis, the process by which germ cells are formed. A unique event in which the chromosome number is reduced from diploid (46 chromosomes) to haploid (23 chromosomes). Also called first meiotic division or first meiosis.
(12 Dec 1998)
reduction en masse Reduction of hernial sac and contents, so that intestinal obstruction is still present.
(05 Mar 2000)
reduction mammaplasty Plastic surgery of the breast to reduce its size and (frequently) to improve its shape and position.
(05 Mar 2000)
reduction nucleus A nucleus that degenerates in the cell during the changes incident to fertilization.
(05 Mar 2000)
reduction of chromosomes The process during meiosis whereby one member of each homologous pair of chromosomes is distributed to a sperm or ovum; the diploid set of chromosomes (46 in humans) is thus reduced to the haploid set in each gamete; union of the sperm and ovum then restores the diploid or somatic number in the one-cell zygote.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduction
    °¨¼Ò
  • data reduction
    (Àü»ê)µ¥ÀÌÅÍ Á¤¸®(¾ÐÃà)
  • reduction
    Ãà¼Ò;»è°¨;°¨¼Ò;ÇÒÀÎ;Ãà»ç;Ã൵;º¯Çü;Á¤¸®;´Ü¼øÈ­;ÀûÇÕ;ÀûÀÀ;Ç׺¹;±Í¼ø;ÇÔ¶ô;¾àºÐ;ȯ»ê;ȯ¿ø¹ý;º¹À§;Á¤º¹(¼ú);ȯ¿ø¹ý;°³°Ý¹ý;¼öÁ¤(°üÃøÁßÀÇ ¿ÀÂ÷ÀÇ º¸Á¤);°¨¼öºÐ¿­
  • reduction division
    °¨¼ö ºÐ¿­
  • reduction formula
    ȯ¿ø(ȯ»ê) °ø½Ä
  • reduction gear
    °¨¼Ó ±â¾î
  • tax reduction
    °¨¼¼
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á